FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804645708> ?p ?o ?g. }

• W2804645708 endingPage "36" @default.
• W2804645708 startingPage "30" @default.
• W2804645708 abstract "Abstract Background Previous studies have suggested that varenicline, an α4β2 nicotinic receptor partial agonist, and α7 nicotinic receptor full agonist, may be effective for the treatment of methamphetamine (MA) dependence due to dopaminergic effects, relief of glutamatergic and cognitive dysfunction, and activation of nicotinic cholinergic systems. This study aimed to determine if varenicline (1 mg BID) resulted in reduced methamphetamine use compared to placebo among treatment-seeking MA-dependent volunteers. Methods Treatment-seeking MA-dependent volunteers were randomized to varenicline 1 mg twice daily (n = 27) or placebo (n = 25) and cognitive behavioral therapy for 9 weeks. The primary outcomes were the proportion of participants achieving end-of-treatment-abstinence (EOTA, MA-negative urine specimens during weeks 8 and 9) and the treatment effectiveness score (TES, number of MA-negative urine specimens) for varenicline versus placebo. Results There was no significant difference in EOTA between varenicline (15%, 4/27) and placebo (20%, 5/25; p = 0.9). There was some suggestion that urinary confirmed medication compliance corresponded with EOTA in the varenicline condition, though it did not reach statistical significance, OR = 1.57 for a 100 ng/ml increase in urine varenicline, p = 0.10, 95% CI (0.99, 3.02). There was no significant difference in mean TES in the varenicline condition (8.6) compared to the placebo condition (8.1), and treatment condition was not a statistically significant predictor of TES, IRR = 1.01, p = 0.9, 95% CI (0.39, 2.70). Conclusions The results of this study indicate that 1 mg varenicline BID was not an effective treatment for MA dependence among treatment-seeking MA-dependent volunteers." @default.
• W2804645708 created "2018-06-01" @default.
• W2804645708 creator A5009963710 @default.
• W2804645708 creator A5011602667 @default.
• W2804645708 creator A5017059128 @default.
• W2804645708 creator A5028749357 @default.
• W2804645708 creator A5031442075 @default.
• W2804645708 creator A5035063622 @default.
• W2804645708 creator A5042151763 @default.
• W2804645708 creator A5055503350 @default.
• W2804645708 creator A5059600880 @default.
• W2804645708 creator A5068139431 @default.
• W2804645708 date "2018-08-01" @default.
• W2804645708 modified "2023-10-16" @default.
• W2804645708 title "Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial" @default.
• W2804645708 cites W1483496794 @default.
• W2804645708 cites W1510604256 @default.
• W2804645708 cites W1602668515 @default.
• W2804645708 cites W1871254996 @default.
• W2804645708 cites W1936223934 @default.
• W2804645708 cites W1968753027 @default.
• W2804645708 cites W1979313563 @default.
• W2804645708 cites W1982554516 @default.
• W2804645708 cites W2003590685 @default.
• W2804645708 cites W2006833508 @default.
• W2804645708 cites W2015579543 @default.
• W2804645708 cites W2020457020 @default.
• W2804645708 cites W2050944428 @default.
• W2804645708 cites W2051244114 @default.
• W2804645708 cites W2052464626 @default.
• W2804645708 cites W2052534327 @default.
• W2804645708 cites W2067642107 @default.
• W2804645708 cites W2077348308 @default.
• W2804645708 cites W2107200746 @default.
• W2804645708 cites W2116725269 @default.
• W2804645708 cites W2122771538 @default.
• W2804645708 cites W2132245264 @default.
• W2804645708 cites W2156122963 @default.
• W2804645708 cites W2164593389 @default.
• W2804645708 cites W2165758561 @default.
• W2804645708 cites W2167796542 @default.
• W2804645708 cites W2174879506 @default.
• W2804645708 cites W2472306680 @default.
• W2804645708 cites W4294253676 @default.
• W2804645708 doi "https://doi.org/10.1016/j.drugalcdep.2018.04.023" @default.
• W2804645708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6391991" @default.
• W2804645708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29860057" @default.
• W2804645708 hasPublicationYear "2018" @default.
• W2804645708 type Work @default.
• W2804645708 sameAs 2804645708 @default.
• W2804645708 citedByCount "10" @default.
• W2804645708 countsByYear W28046457082019 @default.
• W2804645708 countsByYear W28046457082020 @default.
• W2804645708 countsByYear W28046457082021 @default.
• W2804645708 countsByYear W28046457082022 @default.
• W2804645708 countsByYear W28046457082023 @default.
• W2804645708 crossrefType "journal-article" @default.
• W2804645708 hasAuthorship W2804645708A5009963710 @default.
• W2804645708 hasAuthorship W2804645708A5011602667 @default.
• W2804645708 hasAuthorship W2804645708A5017059128 @default.
• W2804645708 hasAuthorship W2804645708A5028749357 @default.
• W2804645708 hasAuthorship W2804645708A5031442075 @default.
• W2804645708 hasAuthorship W2804645708A5035063622 @default.
• W2804645708 hasAuthorship W2804645708A5042151763 @default.
• W2804645708 hasAuthorship W2804645708A5055503350 @default.
• W2804645708 hasAuthorship W2804645708A5059600880 @default.
• W2804645708 hasAuthorship W2804645708A5068139431 @default.
• W2804645708 hasBestOaLocation W28046457082 @default.
• W2804645708 hasConcept C118552586 @default.
• W2804645708 hasConcept C126322002 @default.
• W2804645708 hasConcept C142724271 @default.
• W2804645708 hasConcept C15744967 @default.
• W2804645708 hasConcept C168563851 @default.
• W2804645708 hasConcept C204787440 @default.
• W2804645708 hasConcept C27081682 @default.
• W2804645708 hasConcept C2777053506 @default.
• W2804645708 hasConcept C2779547902 @default.
• W2804645708 hasConcept C2780376393 @default.
• W2804645708 hasConcept C2991744798 @default.
• W2804645708 hasConcept C48856860 @default.
• W2804645708 hasConcept C71924100 @default.
• W2804645708 hasConceptScore W2804645708C118552586 @default.
• W2804645708 hasConceptScore W2804645708C126322002 @default.
• W2804645708 hasConceptScore W2804645708C142724271 @default.
• W2804645708 hasConceptScore W2804645708C15744967 @default.
• W2804645708 hasConceptScore W2804645708C168563851 @default.
• W2804645708 hasConceptScore W2804645708C204787440 @default.
• W2804645708 hasConceptScore W2804645708C27081682 @default.
• W2804645708 hasConceptScore W2804645708C2777053506 @default.
• W2804645708 hasConceptScore W2804645708C2779547902 @default.
• W2804645708 hasConceptScore W2804645708C2780376393 @default.
• W2804645708 hasConceptScore W2804645708C2991744798 @default.
• W2804645708 hasConceptScore W2804645708C48856860 @default.
• W2804645708 hasConceptScore W2804645708C71924100 @default.
• W2804645708 hasFunder F4320337347 @default.
• W2804645708 hasLocation W28046457081 @default.
• W2804645708 hasLocation W28046457082 @default.
• W2804645708 hasLocation W28046457083 @default.

• next